A third of patients in a clinical trial had tumors shrink while taking a genetically engineered treatment known as RP1.

While the fianlimab arm showed a numerical improvement in progression-free survival, the difference was not statistically ...

FDA rejects melanoma drug vusolimogene with nivolumab, citing insufficient evidence from Replimune’s phase 2 and 3 trials.

I've always been vigilant about monitoring my skin for unusual spots since I have a family history of melanoma in addition to ...

I haven’t been a sun worshipper since my thirties, so skin cancer wasn’t even on my radar.

Shortly after 3 p.m. on May 12, RCMP were called to the home near the Highway 3 and... The Lumby & District Wildlife Association is celebrating the success of its annual Mabel Lake Fishing Derby, ...

Aboard Air Force One (AFP) | 15/05/2026 - 13:11:51 | Trump says Xi 'feels strongly' Iran can't have nuclear weapon ...